^
    3years
    Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma (clinicaltrials.gov)
    P1, N=13, Recruiting, Peking University | Not yet recruiting --> Recruiting
    Clinical • Enrollment open
    |
    GPC3 (Glypican 3)
    |
    CT0181
    over3years
    Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma (clinicaltrials.gov)
    P1, N=1, Not yet recruiting, Peking University
    Clinical • New P1 trial
    |
    GPC3 (Glypican 3)
    |
    CT0181